Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
0.6385
-0.0411 (-6.05%)
May 18, 2026, 4:00 PM EDT - Market closed
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of $26.08 million as of May 19, 2026. Its market cap has decreased by -29.10% in one year.
Market Cap
26.08M
Enterprise Value
-28.77M
1-Year Change
-29.10%
Ranking
Category
Stock Price
$0.64
Market Cap Chart
Since the IPO on April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from $579.09M to $26.08M, a decrease of -95.50%. That is a compound annual growth rate of -45.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 26.08M | -8.76% |
| Dec 31, 2025 | 28.59M | -41.18% |
| Dec 31, 2024 | 48.60M | -65.85% |
| Dec 29, 2023 | 142.31M | 62.36% |
| Dec 30, 2022 | 87.65M | -77.38% |
| Dec 31, 2021 | 387.51M | -33.08% |
| Apr 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kyntra Bio | 27.65M |
| Palatin Technologies | 27.52M |
| Skye Bioscience | 27.32M |
| NeuroSense Therapeutics | 27.23M |
| Sensei Biotherapeutics | 26.69M |
| Traws Pharma | 26.67M |
| Dyadic International | 26.24M |
| ABVC BioPharma | 26.19M |